Imagine having COPD, where every breath is a struggle, and then finding your sleep is also shattered by pauses in breathing. That's the reality for many people with this lung condition, especially if they also carry extra weight. A new, small analysis looked at whether the weight loss medication liraglutide could help with this double burden.
The study involved 40 people with COPD and overweight or obesity. It found that those who received liraglutide for 40 weeks saw a meaningful reduction in the severity of their sleep apnea—measured by fewer breathing pauses and drops in oxygen levels per hour—compared to those on a placebo. Participants also reported feeling better in some aspects of their daily life and general health. However, they didn't report feeling less sleepy during the day.
It's crucial to understand what this study is and isn't. This was a secondary, exploratory look at data from a trial, not a main finding the original study was designed to prove. We don't know about side effects from this analysis, and with only 40 people involved, the results are preliminary. The connection is an association, not proof the drug caused the improvements. This is a promising signal that deserves a closer, more definitive look in future research designed specifically to answer this question.